Cell/Gene Tx channel feed – Endpoints News

Cell/Gene Tx channel feed

AbbVie offloads UK site for $119M in sale to Chinese cell and gene therapy player Pharmaron

5 years ago

In the latest big investment in gene therapy manufacturing, Biogen commits $200M to a major new facility in NC

5 years ago

Swiss CDMO Celonic finds a home at Novartis' Stein hub, plans to add 250 new jobs centered on next-gen drugs

5 years ago

As allogeneic cell therapy approaches flourish, Century loads up $160M to scale iPSC platform for CAR-T, CAR-NK

5 years ago

With new $106M crossover round, Tenaya preps heart failure programs for the clinic — and maybe an IPO

5 years ago

Looking to take advantage of 'silenced' enzymes, SalioGen emerges from stealth with eyes set on gene therapy 3.0

5 years ago

NK cell therapy player Artiva makes some more noise, pulling in $120M Series B less than a month after Merck deal

5 years ago

The mRNA era is here. MPM believes the future belongs to oRNA — and Big Pharma wants a seat at the table

5 years ago

Bristol Myers scales up cell therapy production with liso-cel nod in hand and another approval maybe on the way

5 years ago

Jim Wilson's team hands Precision Bio a big proxy win for its PCSK9 gene editing tech with 3-year monkey data

5 years ago

Century Therapeutics boosts iPSC manufacturing space in New Jersey as part of company wide expansion

5 years ago

Bluebird hits the brakes on LentiGlobin studies, Zynteglo marketing after AML, myelodysplastic syndrome cases spur fresh safety concerns

5 years ago

George Church and an entrepreneurial postdoc join the hunt for AAV 2.0 with a new vector-cloaking technology

5 years ago

Dyno sketches tens of thousands of viable next-gen AAV capsids with the help of machine learning — paper

5 years ago

AbbVie taps Jennifer Doudna startup for licensing deal worth up to $300M for 2 'off-the-shelf' CRISPR-edited CAR-Ts

5 years ago

With a roster of gene therapy vets, Forbion makes a bet on 'relatively empty space' of vectorized antibodies

5 years ago

'Industrializing the production of cells': Another iPSC player joins the quest for off-the-shelf cell therapies

5 years ago

FDA lifts clinical hold on Mustang Bio's lentiviral gene therapy, paving the way for quick jump into pivotal trial

5 years ago

Khosla Ventures helps seed a next-gen regenerative medicines startup boasting AI-based stem cell culturing technology

5 years ago

Though still struggling, Bellicum can resume trial on CAR-T hopeful after FDA lifts clinical hold

5 years ago

The diabetes 'cure' Vertex acquired in its 2019 Semma buyout? It's headed to the clinic

5 years ago

Bayer and AskBio expand grand gene therapy ambitions with new Parkinson's program, top scientist

5 years ago

'Bluest of blue-chip investors' pump $94M into Sekar Kathiresan's quest to bring CRISPR to the heart

5 years ago

Cognate doubles manufacturing capacities in Memphis, Europe, as demand for cell and gene therapies skyrockets

5 years ago

First page Previous page 40 41 424344 45 46 Next page Last page